Profile picture

Miss Natalia Atzemian

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)
Membership: ESC Professional Member HFA Member
Follow
Biography
I am a Ph.D. candidate in the BioMedicine Ph.D. Program at the University of Zurich, conducting my research at the Center for Translational and Experimental Cardiology (CTEC) under the mentorship of Prof. Paneni. My PhD project focuses on the molecular and epigenetic drivers of kidney dysfunction in cardiometabolic disease, particularly within the cardiorenal axis of HFpEF, using advanced multi-omic approaches to uncover cell-specific mechanisms and identify targeted therapeutic strategies. I hold a B.Sc. in Molecular Biology and Genetics and an M.Sc. in Clinical Pharmacology and Therapeutics from Democritus University of Thrace (Greece). My academic and research interests lie at the intersection of cardiovascular epigenomics, renal biology, and precision medicine, with a vision to advance mechanistic insights and innovative treatment strategies for cardiometabolic disorders.
Logo ESC

Contributor content

Integrated multi-omics reveals epigenetic control of renal damage in HFpEF
Presentation
Integrated multi-omics reveals epigenetic control of renal damage in HFpEF
Epigenetic editing of chromatin readers rescues doxorubicin-induced endothelial senescence and vascular dysfunction
Presentation
Epigenetic editing of chromatin readers rescues doxorubicin-induced endothelial senescence and vascular dysfunction
Epigenetic control of renal dysfunction in HFpEF: chromatin remodeling as a driver of cardio-renal maladaptation
Presentation
Epigenetic control of renal dysfunction in HFpEF: chromatin remodeling as a driver of cardio-renal maladaptation
Epigenomic rewiring of the cardio-renal axis in obesity-related heart failure with preserved ejection fraction
Presentation
Epigenomic rewiring of the cardio-renal axis in obesity-related heart failure with preserved ejection fraction
Insights into type 2 diabetes mellitus in atrial fibrillation patients: a proteomics approach
Presentation
Insights into type 2 diabetes mellitus in atrial fibrillation patients: a proteomics approach
DNA methylation of ADAMTS7 gene promoter in direct oral anticoagulant-induced bleeding in patients with atrial fibrillation
Presentation
DNA methylation of ADAMTS7 gene promoter in direct oral anticoagulant-induced bleeding in patients with atrial fibrillation

ESC 365 is supported by